JUNO THERAPEUTICS INC's ticker is JUNO and the CUSIP is 48205A109. A total of 243 filers reported holding JUNO THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.72 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $703,000 | +2.8% | 15,377 | +0.8% | 0.01% | +16.7% |
| Q3 2017 | $684,000 | +64.4% | 15,254 | +9.5% | 0.01% | +50.0% |
| Q2 2017 | $416,000 | -29.7% | 13,926 | -47.8% | 0.00% | -20.0% |
| Q1 2017 | $592,000 | -59.6% | 26,689 | -65.7% | 0.01% | -58.3% |
| Q4 2016 | $1,465,000 | +85.7% | 77,716 | +195.7% | 0.01% | +50.0% |
| Q3 2016 | $789,000 | +415.7% | 26,282 | +560.7% | 0.01% | +700.0% |
| Q2 2016 | $153,000 | -53.8% | 3,978 | -36.0% | 0.00% | -50.0% |
| Q2 2015 | $331,000 | – | 6,214 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 25,948,799 | $1,132,937,000 | 100.00% |
| Biomark Capital Management Co. LLC | 1,602,562 | $70,465,000 | 85.76% |
| Omega Fund Management, LLC | 1,229,512 | $54,062,000 | 30.09% |
| Clarius Group, LLC | 218,942 | $9,626,000 | 2.93% |
| BB BIOTECH AG | 1,305,000 | $57,381,000 | 1.62% |
| Casdin Capital, LLC | 17,500 | $769,000 | 0.68% |
| Rock Springs Capital Management LP | 197,001 | $8,662,000 | 0.66% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 38,850 | $1,708,000 | 0.55% |
| ArrowMark Colorado Holdings LLC | 383,749 | $16,873,000 | 0.46% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 68,848 | $3,027,000 | 0.38% |